The Chromatography Forum

of Delaware Valley

Troy Halseth completed his PhD in Medicinal Chemistry at the University of Michigan where his research focused on developing nanoparticle-based therapies for lysosomal storage disorders. He then joined Merck as a Senior Scientist on the Vaccine Analytical Research and Development team in 2023 where he now supports characterization of a range of vaccine modalities using Field Flow Fractionation and Multi-Angle Light Scattering.